Cargando…

Scoping review update on somatic symptom disorder that includes additional Chinese data

Somatic symptom disorder (SSD) is a new diagnosis introduced into the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), which is expected to solve the diagnostic difficulties of patients with medically unexplained symptoms. Based on the previous work, this review aims to...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Heng, Manglike, Ayinuer, Chen, Yixiao, Liu, Ziming, Fritzsche, Kurt, Lu, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277133/
https://www.ncbi.nlm.nih.gov/pubmed/37337547
http://dx.doi.org/10.1136/gpsych-2022-100942
_version_ 1785060225150091264
author Wu, Heng
Manglike, Ayinuer
Chen, Yixiao
Liu, Ziming
Fritzsche, Kurt
Lu, Zheng
author_facet Wu, Heng
Manglike, Ayinuer
Chen, Yixiao
Liu, Ziming
Fritzsche, Kurt
Lu, Zheng
author_sort Wu, Heng
collection PubMed
description Somatic symptom disorder (SSD) is a new diagnosis introduced into the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), which is expected to solve the diagnostic difficulties of patients with medically unexplained symptoms. Based on the previous work, this review aims to comprehensively synthesise updated evidence related to SSD from recent years in English publications and, more extensively, from data published in Chinese language journals. The scoping review update was based on an earlier scoping review and included Chinese language publication data from China National Knowledge Internet (CNKI), WANFANG and WEIPU between January 2013 and May 2022 and data from PubMed, PsycINFO, and Cochrane Library between June 2020 and May 2022. Initially, 2 984 articles were identified, of which 63 full texts were included for analysis. In China, SSD is mainly applied in scientific research, but it also shows good predictive validity and clinical application potential. The mean frequency of SSD was 4.5% in the general population, 25.2% in the primary care population and 33.5% in diverse specialised care settings. Biological factors, such as brain region changes and heart rate variability, are associated with the onset of SSD. Psychological impairment related to somatic symptoms is the best predictor of prognosis. While adolescent SSD was significantly associated with family function, SSD overall is associated with an increased dysfunction of cognition and emotion, decreased quality of life, and high comorbidity with anxiety and depressive disorders. Further research is needed on suicide risk and cultural and gender-related issues. Updating the data of Chinese language studies, our research enriches the evidence-based findings related to the topics addressed in the text sections of the SSD chapter of DSM-5. However, research gaps remain about SSD reliability, population-based prevalence, suicide risk, and cultural and gender-related issues.
format Online
Article
Text
id pubmed-10277133
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-102771332023-06-19 Scoping review update on somatic symptom disorder that includes additional Chinese data Wu, Heng Manglike, Ayinuer Chen, Yixiao Liu, Ziming Fritzsche, Kurt Lu, Zheng Gen Psychiatr Review Somatic symptom disorder (SSD) is a new diagnosis introduced into the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), which is expected to solve the diagnostic difficulties of patients with medically unexplained symptoms. Based on the previous work, this review aims to comprehensively synthesise updated evidence related to SSD from recent years in English publications and, more extensively, from data published in Chinese language journals. The scoping review update was based on an earlier scoping review and included Chinese language publication data from China National Knowledge Internet (CNKI), WANFANG and WEIPU between January 2013 and May 2022 and data from PubMed, PsycINFO, and Cochrane Library between June 2020 and May 2022. Initially, 2 984 articles were identified, of which 63 full texts were included for analysis. In China, SSD is mainly applied in scientific research, but it also shows good predictive validity and clinical application potential. The mean frequency of SSD was 4.5% in the general population, 25.2% in the primary care population and 33.5% in diverse specialised care settings. Biological factors, such as brain region changes and heart rate variability, are associated with the onset of SSD. Psychological impairment related to somatic symptoms is the best predictor of prognosis. While adolescent SSD was significantly associated with family function, SSD overall is associated with an increased dysfunction of cognition and emotion, decreased quality of life, and high comorbidity with anxiety and depressive disorders. Further research is needed on suicide risk and cultural and gender-related issues. Updating the data of Chinese language studies, our research enriches the evidence-based findings related to the topics addressed in the text sections of the SSD chapter of DSM-5. However, research gaps remain about SSD reliability, population-based prevalence, suicide risk, and cultural and gender-related issues. BMJ Publishing Group 2023-06-09 /pmc/articles/PMC10277133/ /pubmed/37337547 http://dx.doi.org/10.1136/gpsych-2022-100942 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Review
Wu, Heng
Manglike, Ayinuer
Chen, Yixiao
Liu, Ziming
Fritzsche, Kurt
Lu, Zheng
Scoping review update on somatic symptom disorder that includes additional Chinese data
title Scoping review update on somatic symptom disorder that includes additional Chinese data
title_full Scoping review update on somatic symptom disorder that includes additional Chinese data
title_fullStr Scoping review update on somatic symptom disorder that includes additional Chinese data
title_full_unstemmed Scoping review update on somatic symptom disorder that includes additional Chinese data
title_short Scoping review update on somatic symptom disorder that includes additional Chinese data
title_sort scoping review update on somatic symptom disorder that includes additional chinese data
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277133/
https://www.ncbi.nlm.nih.gov/pubmed/37337547
http://dx.doi.org/10.1136/gpsych-2022-100942
work_keys_str_mv AT wuheng scopingreviewupdateonsomaticsymptomdisorderthatincludesadditionalchinesedata
AT manglikeayinuer scopingreviewupdateonsomaticsymptomdisorderthatincludesadditionalchinesedata
AT chenyixiao scopingreviewupdateonsomaticsymptomdisorderthatincludesadditionalchinesedata
AT liuziming scopingreviewupdateonsomaticsymptomdisorderthatincludesadditionalchinesedata
AT fritzschekurt scopingreviewupdateonsomaticsymptomdisorderthatincludesadditionalchinesedata
AT luzheng scopingreviewupdateonsomaticsymptomdisorderthatincludesadditionalchinesedata